Width: | 175px |
Class: | Serotonin receptor agonist |
Pubchem: | 17868117 |
Chemspiderid: | 13318696 |
Chebi: | 193061 |
Synonyms: | 4-OH-TMT; 4-hydroxy-N,N,N-trimethyltryptammonium; 4-Hydroxy-N,N,N-trimethyltryptamine; 4-HO-N,N,N-TMT; Dephosphorylated aeruginascin; Dephosphorylaeruginascin |
Iupac Name: | 2-(4-hydroxy-1H-indol-3-yl)ethyl-trimethylazanium |
C: | 13 |
H: | 19 |
N: | 2 |
O: | 1 |
Charge: | + |
Smiles: | C[N+](C)(C)CCC1=CNC2=C1C(=CC=C2)O |
Stdinchi: | 1S/C13H18N2O/c1-15(2,3)8-7-10-9-14-11-5-4-6-12(16)13(10)11/h4-6,9,14H,7-8H2,1-3H3/p+1 |
Stdinchikey: | RMPOMMZKJNCOTM-UHFFFAOYSA-O |
4-HO-TMT, or 4-OH-TMT, also known as 4-hydroxy-N,N,N-trimethyltryptammonium or as dephosphorylated aeruginascin, is a substituted tryptamine derivative and the active form of aeruginascin (4-PO-TMT), analogously to how psilocin (4-HO-DMT) is the active form of psilocybin (4-PO-DMT).[1] [2] [3] [4] 4-HO-TMT is closely related to bufotenidine, the N-trimethyl analogue of serotonin.
Like psilocin, 4-HO-DMT shows affinity for the serotonin 5-HT1A, 5-HT2A, and 5-HT2B receptors. However, its affinities for these receptors are lower than those of psilocin (by 8-, 6-, and 26-fold, respectively). Additionally, in another study, the value of 4-HO-TMT in activating the serotonin 5-HT2A receptor was 324-fold lower than that of psilocin (6800 and 21nM, respectively). Similarly to psilocin, 4-HO-TMT does not bind to the serotonin 5-HT3 receptor. This was in contrast to predictions, as the related compound bufotenidine is a strong and selective serotonin 5-HT3 receptor agonist.
4-HO-TMT is a quaternary trimethyl ammonium compound, and as a result, is less likely to be able to cross the blood–brain barrier (BBB) and enter the central nervous system than other tryptamines. Accordingly, 4-HO-TMT showed no ability to cross an artificial BBB-like membrane in a study.[5] In rodents, 4-HO-TMT showed no head-twitch response (a behavioral proxy of psychedelic effects), hypolocomotion, or hypothermia, in contrast to psilocin and norpsilocin, but similarly to aeruginascin.
A synthetic prodrug of 4-HO-TMT, 4-AcO-TMT, has been developed. It is analogous to psilacetin (4-AcO-DMT), a prodrug of psilocin.